Vivo Capital, LLC Xenon Pharmaceuticals Inc. Transaction History

Vivo Capital, LLC

  • $683 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$10.21 - $14.9 $4.05 Million - $5.91 Million
-396,589 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$8.08 - $17.57 $3.2 Million - $6.97 Million
396,589 New
396,589 $4.5 Million
Q3 2019

Nov 13, 2019
SELL
$8.74 - $10.51 $12.3 Million - $14.8 Million
-1,405,476 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$9.0 - $14.9 $12.6 Million - $20.9 Million
1,405,476 New
1,405,476 $18.6 Million

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.39B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email